Scientists have discovered that aspirin may prevent cancer metastasis by reducing TXA2 levels, which suppress T cells.

As low-dose prophylactic aspirin therapy becomes common among older people, potential risks that are associated with such treatment assume increasing importance. In particular, some clinicians are ...

Research spanning 30 years shows taking aspirin twice weekly reduces colorectal cancer risk by 18%, with greater benefits for those with less healthy life ...